Literature DB >> 30472707

Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project.

Nilka Ríos Burrows1, Joseph A Vassalotti2,3, Sharon H Saydah4, Rebecca Stewart2, Monica Gannon2, Shu-Cheng Chen5, Suying Li5, Sarah Pederson5, Allan J Collins5, Desmond E Williams6.   

Abstract

BACKGROUND: Most people with chronic kidney disease (CKD) are not aware of their condition.
OBJECTIVES: To assess screening criteria in identifying a population with or at high risk for CKD and to determine their level of control of CKD risk factors.
METHOD: CKD Health Evaluation Risk Information Sharing (CHERISH), a demonstration project of the Centers for Disease Control and Prevention, hosted screenings at 2 community locations in each of 4 states. People with diabetes, hypertension, or aged ≥50 years were eligible to participate. In addition to CKD, screening included testing and measures of hemoglobin A1C, blood pressure, and lipids. -
Results: In this targeted population, among 894 people screened, CKD prevalence was 34%. Of participants with diabetes, 61% had A1C < 7%; of those with hypertension, 23% had blood pressure < 130/80 mm Hg; and of those with high cholesterol, 22% had low-density lipoprotein < 100 mg/dL.
CONCLUSIONS: Using targeted selection criteria and simple clinical measures, CHERISH successfully identified a population with a high CKD prevalence and with poor control of CKD risk factors. CHERISH may prove helpful to state and local programs in implementing CKD detection programs in their communities. Published by S. Karger AG, Basel.

Entities:  

Keywords:  Albuminuria; Chronic kidney disease; Detection; Diabetes; Hypertension; Older adults

Mesh:

Year:  2018        PMID: 30472707      PMCID: PMC6624836          DOI: 10.1159/000495082

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  23 in total

Review 1.  Need for chronic kidney disease prevention programs in disadvantaged populations.

Authors:  Norberto Perico; Giuseppe Remuzzi
Journal:  Clin Nephrol       Date:  2015       Impact factor: 0.975

2.  Trends in Prevalence of Chronic Kidney Disease in the United States.

Authors:  Daniel Murphy; Charles E McCulloch; Feng Lin; Tanushree Banerjee; Jennifer L Bragg-Gresham; Mark S Eberhardt; Hal Morgenstern; Meda E Pavkov; Rajiv Saran; Neil R Powe; Chi-Yuan Hsu
Journal:  Ann Intern Med       Date:  2016-08-02       Impact factor: 25.391

3.  A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences.

Authors:  Thomas J Hoerger; John S Wittenborn; Joel E Segel; Nilka R Burrows; Kumiko Imai; Paul Eggers; Meda E Pavkov; Regina Jordan; Susan M Hailpern; Anton C Schoolwerth; Desmond E Williams
Journal:  Am J Kidney Dis       Date:  2010-02-08       Impact factor: 8.860

4.  Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.

Authors:  Allan J Collins; Joseph A Vassalotti; Changchun Wang; Suying Li; David T Gilbertson; Jiannong Liu; Robert N Foley; Shu-Cheng Chen; Thomas J Arneson
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

5.  Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention.

Authors:  Andrew S Levey; Anton C Schoolwerth; Nilka Ríos Burrows; Desmond E Williams; Karma Rabon Stith; William McClellan
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

Review 6.  Glycated hemoglobin standardization--National Glycohemoglobin Standardization Program (NGSP) perspective.

Authors:  Randie R Little
Journal:  Clin Chem Lab Med       Date:  2003-09       Impact factor: 3.694

7.  Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.

Authors:  George L Bakris; Matthew R Weir; Shahnaz Shanifar; Zhongxin Zhang; Janice Douglas; David J van Dijk; Barry M Brenner
Journal:  Arch Intern Med       Date:  2003-07-14

Review 8.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

9.  Epidemiological study of chronic kidney disease progression: a large-scale population-based cohort study.

Authors:  Phisitt Vejakama; Atiporn Ingsathit; John Attia; Ammarin Thakkinstian
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

10.  Metformin Use in Prediabetes Among U.S. Adults, 2005-2012.

Authors:  Eva Tseng; Hsin-Chieh Yeh; Nisa M Maruthur
Journal:  Diabetes Care       Date:  2017-04-03       Impact factor: 19.112

View more
  5 in total

1.  Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease.

Authors:  Eun Hui Bae; Sang Yup Lim; Kyung-Do Han; Tae Ryom Oh; Hong Sang Choi; Chang Seong Kim; Seong Kwon Ma; Soo Wan Kim
Journal:  Hypertension       Date:  2019-08-19       Impact factor: 10.190

2.  Community Screening for Diabetes, Hypertension, Nutrition, and Kidney Disease Among Kenyans.

Authors:  Samuel K Kabinga; Seth O McLigeyo; Ahmed Twahir; John N Ngigi; Nancy N Wangombe; Diviner K Nyarera; Grace W Ngaruiya; Reuben K Chege; McDonald O Ogutu; George M Moturi
Journal:  Kidney Int Rep       Date:  2019-07-05

3.  Scoring model to predict risk of chronic kidney disease in Chinese health screening examinees with type 2 diabetes.

Authors:  Xia Cao; Binfang Yang; Jiansong Zhou
Journal:  Int Urol Nephrol       Date:  2021-11-01       Impact factor: 2.266

4.  Lifestyle changes and kidney function: A 10-year follow-up study in patients with manifest cardiovascular disease.

Authors:  Helena Bleken Østergaard; Imre Demirhan; Jan Westerink; Marianne C Verhaar; Folkert W Asselbergs; Gert J de Borst; L Jaap Kappelle; Frank L J Visseren; Joep van der Leeuw
Journal:  Eur J Clin Invest       Date:  2022-05-27       Impact factor: 5.722

5.  End-stage kidney disease in patients with clinically manifest vascular disease; incidence and risk factors: results from the UCC-SMART cohort study.

Authors:  Helena Bleken Østergaard; Jan Westerink; Marianne C Verhaar; Michiel L Bots; Folkert W Asselbergs; Gert J de Borst; L Jaap Kappelle; Frank L J Visseren; Joep van der Leeuw
Journal:  J Nephrol       Date:  2021-03-13       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.